Hypertrophic osteopathy associated with pulmonary Eikenella corrodens infection in a dog

Hypertrophic Osteopathy Concurrent with an Aberrant Right Subclavian Artery in a Dog

A 13-year-old spayed female cocker spaniel was presented with a 2-month history of swelling in several digits and intermittent hindlimb lameness. Radiographs revealed marked soft-tissue swelling and periosteal new bone formation without cortical bone destruction, characteristic of hypertrophic osteopathy (HO), in the distal parts of all extremities except for the right forelimb. However, no notable findings were detected in thoracic radiographs. An ultrasonography indicated cranial bladder wall thickening, which resolved following antibiotic therapy. Computed tomographic angiography identified a potential underlying cause as an aberrant right subclavian artery (ARSA) originating from the aortic arch, compressing the esophagus and causing mild esophageal cranial dilation to the aberrant vessel. No other intrathoracic or neoplastic lesions were observed. Gastrointestinal symptoms, such as regurgitation, were absent. Although an ARSA was likely the cause of HO, surgical correction was declined by the owner. To the best of our knowledge, this is the first reported case of HO concurrent with ARSA in dogs.

Paraneoplastic hypertrophic osteopathy in 30 dogs

Paraneoplastic hypertrophic osteopathy (pHO) is known to occur in both canine and human cancer patients. While the pathology of pHO is well-described in the dog, very little information exists regarding the true clinical presentation of dogs affected with pHO. The primary objective of this study was to provide a more comprehensive clinical picture of pHO. To this end, we retrospectively identified 30 dogs and recorded data regarding presenting complaints and physical examination (PE) findings on the date of pHO diagnosis. As a secondary objective, any blood test results were also collected from the computerized records. The most common clinical signs included leg swelling, ocular discharge and/or episcleral injection, lameness, and lethargy. The most common haematological and serum biochemical abnormalities included anaemia, neutrophilia and elevated alkaline phosphatase. In addition to presenting a more detailed clinical description of pHO in the dog, these data support the previously described haematological, serum biochemical and PE abnormalities published in individual case reports.

Hypertrophic osteopathy associated with two pulmonary tumours and myocardial metastases in a dog: a case report

CASE HISTORY

A 16-year-old dog was presented to the University of Melbourne Veterinary Clinic and Hospital for dyspnoea and tachypnoea, which had been occurring over the previous 48 h prior to presentation.

CLINICAL FINDINGS

Physical examination findings included marked wheezing and inspiratory noises on thoracic auscultation. Diagnostic tests performed revealed a large pulmonary mass, the presence of hypertrophic osteopathy in the forelimbs and an abnormal myocardium. The patient continued to deteriorate while in hospital, and was euthanased at the owner's request. A post-mortem examination was carried out, which revealed the presence of two separate pulmonary masses, one of which was completely occluding the mainstem bronchus.

DIAGNOSIS

One tumour was histologically classified as an adenocarcinoma, the other as an extraskeletal osteosarcoma. The osteosarcoma had metastasised to the myocardium, spleen and kidneys. The forelimb changes were consistent with hypertrophic osteopathy.

CLINICAL RELEVANCE

This is the first reported case of two separate pulmonary masses in a dog, one of which metastasised to the myocardium. Hypertrophic osteopathy is a common pathological condition associated with a broad spectrum of diseases. The aim of this case report is to highlight the condition and remind clinicians of its relatively common incidence, as well as to prompt clinicians to look for underlying pathology. The current understanding of the pathophysiology of hypertrophic osteopathy is also discussed.